Về Novigenix sa

Về công ty

Novigenix is an innovative Swiss molecular diagnostics company specializing in liquid biopsy for early detection of cancer. Our technology platform is based on human transcriptome gene expression profiling of circulating blood cells and tumor-derived protein markers in combination with state-of-the-art Machine Learning analytical models. Novigenix's predictive molecular signatures provide new and accurate solutions for the early detection of cancer. Our lead product Colox® is a proven molecular blood test designed to significantly reduce mortality from colorectal cancer through early detection and follow-up colonoscopy. Next generation products are currently in development with application of Machine Learning to the full human transcriptome of our proprietary biobank from human clinical trails.